On November 8, 2012, after five inspections and over 15 months of resulting delays, an inspector from Health Canada finally approved the security measures at the Vancouver pharmacy where the MDMA will …
On October 30, 2012, Health Canada conducted its fourth inspection of the pharmacy where the MDMA will be stored for our planned Canadian study of MDMA-assisted psychotherapy for PTSD. We are now required …
On September 7, 2012, Health Canada notified the manager of the pharmacy where the MDMA will be stored for our planned Canadian study of MDMA-assisted psychotherapy for PTSD that the security upgrades …
On December 2, 2011, Health Canada sent a report of the results of their second security inspection to the manager of the pharmacy where the MDMA will be stored for our planned Canadian study of MDMA-assisted …
On October 18, 2011, Health Canada has scheduled a follow-up inspection of the pharmacy for our planned Canadian study of MDMA-assisted psychotherapy for PTSD.
On July 6, 2011, we received a letter from Health Canada (dated June 17, 2011) explaining the results of its May 10 inspection of the Vancouver pharmacy that will be used to store and label the MDMA capsules …
On May 10, 2011, officials from Health Canada completed their inspection of the Vancouver pharmacy that will be used to store the MDMA capsules to be used in our upcoming Canadian study of MDMA-assisted …
Health Canada has confirmed that an inspection of our Canadian MDMA/PTSD study site will take place on February 10, 2011. The study pharmacist is currently preparing the safe for installation at the pharmacy …
On Nov. 1, 2010, Pharmacist Colin Holyk from Kerrisdale Pharmacy resubmitted his application for a “licensed dealer permit” to Health Canada in order to import MDMA for our Canadian MDMA/PTSD …
After more than a month of waiting, Health Canada has requested additional information from the Canadian pharmacist we are working with to obtain import permits and licensing for encapsulating the MDMA …
An official with Health Canada is working to schedule a meeting in June with MAPS-sponsored researcher and Principle Investigator Ingrid Pacey M.D., to discuss the remaining issues in the authorization …
There is good news from our friends north of the U.S. border. We have obtained approval in Canada for our MDMA/PTSD study from both Health Canada (in March 2009) and a Canadian Institutional Review Board …
